Dana-Farber / Harvard Cancer Institute — Boston, Massachusetts

Dana-Farber / Harvard Cancer Institute is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.

Dana-Farber / Harvard Cancer Institute has participated in 2 clinical trials.

Therapeutic areas: Breast Neoplasms, Pancreatic Neoplasms, Anemia.

Sponsors: Celgene, Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana-Farber / Harvard Cancer Institute?

Dana-Farber / Harvard Cancer Institute has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana-Farber / Harvard Cancer Institute conducted?

Dana-Farber / Harvard Cancer Institute has 2 clinical trials on record. Their work covers Breast Neoplasms, Pancreatic Neoplasms, Anemia.

Is Dana-Farber / Harvard Cancer Institute accredited by Crixeo Health?

Dana-Farber / Harvard Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana-Farber / Harvard Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.